Article Text

PDF
Selective serotonin reuptake inhibitors in obsessive-compulsive disorder

Abstract

Since we reviewed the selective serotonin reuptake inhibitor (SSRI) antidepressants two years ago1 two of them, fluoxetine (Prozac - Dista) and fluvoxamine (Faverin - Duphar), have also been licensed for the treatment of patients with obsessive-compulsive disorder. How do these and the other SSRIs available in the UK - paroxetine (Seroxat - SmithKline Beecham) and sertraline (Lustral - Invicta/Pfizer) - compare with clomipramine, a standard drug treatment for this disorder?2,3

Statistics from Altmetric.com

  • Relevant BNF section: 4.3.3

View Full Text

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.